Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

INTRODUCTION: Targeted therapies may impact the natural history of bladder cancer based upon their pharmacokinetics. The Her2/neu receptor tyrosine kinase, overexpressed by half of all primary urothelial carcinomas, has recently been examined as a therapeutic target in bladder cancer in a prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodman, Oscar B, Milowsky, Matthew I, Kaplan, Jodi, Hussain, Maha, Nanus, David M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767151/
https://www.ncbi.nlm.nih.gov/pubmed/19918289
http://dx.doi.org/10.4076/1752-1947-3-9110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767151/
https://www.ncbi.nlm.nih.gov/pubmed/19918289
http://dx.doi.org/10.4076/1752-1947-3-9110

Ejemplares similares